ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

BIOptimizers Lab Pioneers Next-Gen Enzyme and Probiotics Performance with Breakthrough Digestive Supplement Formulations

Reno, NV (Newsworthy.ai) Wednesday Jul 26, 2023 @ 1:35 PM Central —

The global supplement market, which generated $78.1 billion in sales in 2021 is projected to reach a whopping $128 billion by 2028.

And now with tens of thousands of supplements readily available to address a wide spectrum of health issues, consumers are often left wondering about the supplement company behind the label. Can they ultimately be trusted for their claims of purity, potency, and most importantly, performance?

BIOptimizers, a next-gen brain performance and health supplement company, is on a mission to earn consumers' ongoing trust and loyalty. And they’re willing to invest significantly in research and development to do just that.

The company recently announced a breakthrough in product formulations for supplements in the health and wellness industry. The company's lab, which was launched in 2019 with six employees, has tripled its staff to date.

"Our lab focuses on innovation at every level," said Matt Gallant, co-founder of BIOptimizers. "We are proud to be breaking new ground in the supplement industry with our leading-edge product formulations. We might be the only supplement company in the world doing the kind of R&D our lab performs. Our team is dedicated to improving the health and wellness of our customers, and we are excited to see the positive impact our products will have on their lives."

BIOptimizers continues to break new ground in the supplement industry by creating stacks and combinations of molecules that have never been done before. The BIOptimizers lab has created 250 enzyme and 250 probiotic experiments and has validated or invalidated the properties of every commercially available product, seeing all their unique attributes.

Monia Avdic, a Ph.D. and director of the BIOptimizers lab based at the University of Sarajevo in Bosnia, emphasized the importance of their ongoing and expanding research: "Our lab's focus is on enzymes, probiotics, and some revolutionary new health products. Our goal is to maximize their potency, and we are constantly experimenting with new combinations and formulations. We believe that our research will revolutionize the supplement industry and help people achieve optimal health."

For media inquiries and an expert quote on innovations with supplement formulations, contact Matt Gallant at PR@bioptimizers.com or call 800-719-2467.To learn more about how BIOptimizes can transform brain performance, gut health, and sleep, go to: https://bioptimizers.com/

ABOUT BIOPTIMIZERS:

BIOptimizers serves over 162,000 clients in 90 countries worldwide. The catalyst for BIOptimizers' success is a relentless focus on supplement performance, purity, and potency. The guiding BIOptimizers North Star: create exponentially superior products and prove their effectiveness via consistent customer results.

The company was founded by Matt Gallant and Wade Lightheart, who are trainers who previously worked with pro athletes and other top performers. Investing 10+ years in the gym transforming the health and lives of their clients, the two founded a business partnership in 2004 that has since grown to over 100 employees globally.

Biohackers, physicians, and top authorities in health and wellness worldwide trust BIOptimizers and their extensive line of health products. To find out why visit: https://bioptimizers.com


This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.